|
Prostate Cancer: Translational and Emerging Therapies
|
| List Price: | CDN$ 230.50 |
| Price: | CDN$ 186.07 & eligible for FREE Super Saver Shipping on orders over $39. Details |
Availability: Temporarily out of stock. Order now and we'll deliver when available. We'll e-mail you with an estimated delivery date as soon as we have more information. Your credit card will not be charged until we ship the item.
Ships from and sold by Amazon.ca
Product Description
Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention and control. This expertly-written reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.
Product Details
- Amazon Sales Rank: #1987351 in Books
- Published on: 2006-10-04
- Original language: English
- Dimensions: .93" h x 6.38" w x 9.02" l, 1.33 pounds
- Binding: Hardcover
- 330 pages
Editorial Reviews
Book Info
Walter Reed Army Medical Center, Washington, D.C. Current Clinical Oncology Series. Current diagnostic and new therapeutic techniques in prostate cancer, for oncologists. 32 U.S. contributors. DNLM: Prostate Neoplasms.
From the Publisher
A comprehensive overview regarding the diagnosis of prostate cancer and its management by hormonal therapy, surgery and radiopharmaceuticals. Emphasizes therapeutic strategies in order to control this disease. Features new advances in prostate cancer and the current status of the most crucial controversial issues.
